The worker received the vaccine Tuesday at Bartlett Regional Hospital. Ten minutes after taking the vaccine, she “showed signs of an anaphylactic reaction, with increased heart rate, shortness of breath, and rash and redness,” according to Dr. Lindy Jones, Bartlett’s emergency manager. . “She was given adrenaline and Benadryl, she was admitted to the hospital and put on an intravenous adrenaline infusion. His reaction was serious but did not endanger his life.
“During that time, she was still excited about receiving the vaccine and the benefits it would bring her in the future,” Jones said. The hospital statement said she “always encourages her colleagues to get vaccinated.”
A second healthcare worker, a man, suffered a less severe allergic reaction to the vaccine on Wednesday at the same hospital. Ten minutes after receiving the injection, the man felt “eye bags, dizziness and throat irritation,” Bartlett Hospital said in a statement. “His reaction was not considered anaphylaxis. ”
“He felt completely back to normal within an hour and was released,” after emergency room treatment with epinephrine, Pepcid and Benadryl, according to the hospital, which noted: ” He, too, doesn’t want his experience to negatively impact his colleagues lining up for the vaccine. ”
Infection prevention hospital Charlee Gribbon, who is in charge of the staff immunization program, said Bartlett “expected these things and we had all the right systems in place.”
The hospital confirmed that 144 of its staff had been vaccinated as of Wednesday evening, out of a total of around 400 who requested it. Data on the two allergic reactions were shared with the National Centers for Disease Control and Prevention (CDC).
So far, Bartlett’s two workers have been the only cases of allergic reactions to the Pfizer vaccine in the country, according to Dr Jay Butler, CDC deputy director for infectious diseases.
The Pfizer vaccine cleared the FDA for emergency use after clinical trials showed the vaccine to be nearly 95% effective in preventing COVID-19 infection in adults aged 18 to 64. None of the 44,000 participants in the Phase 3 clinical trial experienced significant adverse effects. reactions.
Dr Anthony Fauci, in an interview with CNBC, reminded viewers that vaccine safety goes “beyond the limits” of clinical trials. “Once you decide to distribute the vaccine widely, you are talking about millions and tens of millions and ultimately hundreds of millions of doses. So you can see reactions that you haven’t seen in clinical trials, ”he said Wednesday.
British health officials last weekthat people with a history of “significant” allergic reactions to vaccines, drugs, or food should not receive Pfizer’s vaccine. Two healthcare workers there had “adverse reactions” after taking the drug.
“We expected that a side effect like this could occur after reports of anaphylaxis were made in England after people there were given the Pfizer-BioNTech COVID-19 vaccine,” said Wednesday the Chief Medical Officer of Alaska, Dr. Anne Zink. “All sites that are licensed to provide vaccines in Alaska must have medication on hand to deal with an allergic reaction and that was the case in Juneau. ”